Research: CBG and CBC effective against lung cancer cells in lab

Recent laboratory research shows that the cannabinoids CBG and CBC can kill lung cancer cells. The study, published in the Hanf Magazin, examined the effects of these compounds on cancer cells in a controlled environment.

CBG (cannabigerol) and CBC (cannabichromeen) are lesser-known components of the hemp plant. Both have been linked to certain health benefits in previous studies. This research focused specifically on their potential role in combating lung cancer cells.

According to the source, the results were obtained in a laboratory setting, which means that the effects have not yet been tested in the human body. Further research is needed to confirm the results and investigate the possible applications in healthcare.

The Hanf Magazin emphasizes that these findings give hope for future research into the role of cannabinoids in cancer therapy, but that much work is still needed before concrete applications can be developed.

This report is a summary based on the mentioned source and is not medical advice. Always consult a doctor or pharmacist if you have complaints.